Advances in Age-related Macular Degeneration Understanding and Therapy

While the development of anti-vascular endothelial growth factor (anti-VEGF) as a therapy for neovascular age-related macular degeneration (AMD) was a great success, the pathologic processes underlying dry AMD that eventually leads to photoreceptor dysfunction, death, and vision loss remain elusive...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Joan W, Bagheri, Saghar, Vavvas, Demetrios G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683729/
https://www.ncbi.nlm.nih.gov/pubmed/29142592
http://dx.doi.org/10.17925/USOR.2017.10.02.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683729/
https://www.ncbi.nlm.nih.gov/pubmed/29142592
http://dx.doi.org/10.17925/USOR.2017.10.02.119

Ejemplares similares